Giant A&D Pharma taps into private clinics market
A&D Pharma, the largest pharmaceutical group on the Romanian market, with 364.6 million euros in turnover in the first nine months of last year, will enter the private clinics market through Anima Medical Services SRL, according to a company release.
A&D Pharma, the largest pharmaceutical group on the Romanian
market, with 364.6 million euros in turnover in the first nine
months of last year, will enter the private clinics market through
Anima Medical Services SRL, according to a company release. The
private clinics market is estimated to be worth around 400 million
euros, being one of the few sectors that continue to grow and
generate profits.
“A&D Pharma confirms its interest for the medical services
market and is currently recruiting doctors and nurses for a future
provider of medical services,” said company representatives. The
group has published recruitment ads for doctor positions “for a
medical clinic in Bucharest” on specialised websites.
This will make A&D Pharma the second company in the drug
industry to expand onto this segment, after the investment of
Polisano, controlled by doctor Ilie Vonica, in private clinics, in
vitro fertilisation centres and dialysis centres. However, the
founders of A&D Pharma are not completely new at the foreign
medical services sector, where they have been controlling the
Diagnosis Medical Centre, through investment fund Gemisa
Investments, since as early as in 2007.
A&D Pharma’s activity has so far focused on the drug business,
through the development of three divisions. The most visible one is
Sensiblu drugstore chain, which operates an around 220-store
network, and which saw the highest rise within the group, of 41% in
RON (22% in euros) in the first nine months of 2009. The biggest
division is the distribution one, Mediplus, but there is also a
sales & marketing company.
A&D Pharma has been listed on the main market of the London
Stock Exchange since 2006, with the latest transactions being
concluded at 3.6 euros/GDR, which amounts to a capitalisation of
120 million euros.
The controlling interest of A&D Pharma is held by businessmen
Walid Abboud, Ludovic Robert, and Roger Akoury.
A minority stake is held by the managers, and the rest is traded on
the Stock Exchange. The group employs around 3,000 people.
-
Ionuț Daniel Coleașă, COO, CITR: Insolvența este un indicator întârziat. Anul acesta s-au văzut dificultățile financiare din ultimii trei-patru ani. Astăzi, 40 de companii din 100 din agricultură au probleme financiareRetail&Agrobusiness · 13 noiembrie 2026
-
Biletele STB s-ar putea scumpi de la 3 la 5 lei. Remus Borza, administratorul judiciar STB: Unii pot băga mâna în buzunar să scoată 3-5 lei. La Cluj, 7 lei biletul de călătorie valabil 60 de minuteEveniment · 13 noiembrie 2026
-
Cum arată situația de la STB: Jumătate dintre cei 10.000 de angajați au legături de rudenie. O familie are 20 de membri în companie, iar unii șoferi au câștigat 18.000 de lei net pe lunăEveniment · 13 noiembrie 2026